PTCT Earnings Ptc Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.03 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 7.78 | 2026-02-19 | 10-K |
| Q3 2025 | 2025-09-30 | 9.45 | 2025-11-04 | 10-Q |
| Q2 2025 | 2025-06-30 | 9.29 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | 10.04 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -4.73 | 2026-02-19 | 10-K |
| Q3 2025 | 2024-09-30 | -3.88 | 2025-11-04 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.49 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.20 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | -8.37 | 2026-02-19 | 10-K |
| Q3 2024 | 2023-09-30 | -6.31 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -4.55 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.88 | 2024-04-25 | 10-Q |
| FY 2024 | 2022-12-31 | -7.79 | 2025-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | -5.43 | 2023-10-26 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.91 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.78 | 2023-04-27 | 10-Q |
| FY 2023 | 2021-12-31 | -7.43 | 2024-02-29 | 10-K |
| Q3 2022 | 2021-09-30 | -5.41 | 2022-10-27 | 10-Q |
| Q2 2022 | 2021-06-30 | -3.51 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.